DK1645626T3 - Cellelinie - Google Patents

Cellelinie

Info

Publication number: DK1645626T3
Authority: DK; Denmark
Prior art keywords: cell line; cell lines; relates; present; accession nos
Prior art date: 2004-09-30

Application number

DK05255932T

Other languages

English (en)

Inventor

John Sinden

Kenneth Pollack

Paul Stroemer

Original Assignee

Reneuron Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-30

Filing date

2005-09-23

Publication date

2008-01-21

2004-09-30 Priority claimed from GB0421753A external-priority patent/GB0421753D0/en

2004-11-23 Priority claimed from GB0425767A external-priority patent/GB0425767D0/en

2004-12-20 Priority claimed from GB0427830A external-priority patent/GB0427830D0/en

2005-09-23 Application filed by Reneuron Ltd filed Critical Reneuron Ltd

2008-01-21 Application granted granted Critical

2008-01-21 Publication of DK1645626T3 publication Critical patent/DK1645626T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Neurology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Zoology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Developmental Biology & Embryology (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Semiconductor Memories (AREA)
Semiconductor Lasers (AREA)
Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DK05255932T 2004-09-30 2005-09-23 Cellelinie DK1645626T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0421753A GB0421753D0 (en)	2004-09-30	2004-09-30	Cell line
GB0425767A GB0425767D0 (en)	2004-11-23	2004-11-23	Cell line
GB0427830A GB0427830D0 (en)	2004-12-20	2004-12-20	Cell line

Publications (1)

Publication Number	Publication Date
DK1645626T3 true DK1645626T3 (da)	2008-01-21

Family

ID=35744948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK05255932T DK1645626T3 (da)	2004-09-30	2005-09-23	Cellelinie

Country Status (9)

Country	Link
US (3)	US7416888B2 (da)
EP (1)	EP1645626B1 (da)
JP (1)	JP5036156B2 (da)
AT (1)	ATE373081T1 (da)
AU (1)	AU2005218041B2 (da)
CA (1)	CA2521421C (da)
DE (1)	DE602005002430T2 (da)
DK (1)	DK1645626T3 (da)
ES (1)	ES2294650T3 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9518606D0 (en) *	1995-09-12	1995-11-15	Inst Of Psychiatry	Neural transplantation
ES2294650T3 (es) *	2004-09-30	2008-04-01	Reneuron Limited	Linea celular.
GB0822246D0 (en)	2008-12-05	2009-01-14	Reneuron Ltd	Composition
GB0902034D0 (en)	2009-02-06	2009-03-11	Reneuron Ltd	Method
WO2011015573A1 (en)	2009-08-03	2011-02-10	Galapagos Nv	Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases
GB201011589D0 (en)	2010-07-09	2010-08-25	Reneuron Ltd	Therapeutic cells
GB201302468D0 (en)	2013-02-12	2013-03-27	Reneuron Ltd	Stem cell product
CA2868506C (en) *	2012-04-03	2023-10-24	Reneuron Limited	Stem cell microparticles
WO2014013258A1 (en)	2012-07-19	2014-01-23	Reneuron Limited	Stem cell microparticles
ES2927175T3 (es)	2013-02-12	2022-11-03	Reneuron Ltd	Método de producción de micropartículas
GB201317887D0 (en)	2013-10-09	2013-11-20	Reneuron Ltd	Product
GB201317889D0 (en)	2013-10-09	2013-11-20	Reneuron Ltd	Product and use
US20200108100A1 (en) *	2018-10-08	2020-04-09	Reneuron Limited	Neural stem cell therapy for stroke
KR20210102195A (ko)	2018-10-12	2021-08-19	레뉴런 리미티드	조건부 불멸화를 위한 제어가능한 트랜스진을 포함하는 유도된 만능 세포
GB201911464D0 (en)	2019-08-09	2019-09-25	Reneuron Ltd	Genetic modification site
GB201919021D0 (en)	2019-12-20	2020-02-05	Reneuron Ltd	Nucleic acid constructs for delivering polynucleotides into exosomes
GB202005494D0 (en)	2020-04-15	2020-05-27	Reneuron Ltd	Induced pluripotent cell comprising a contollable transgene for conditional immortalisation
GB202114441D0 (en)	2021-10-08	2021-11-24	Reneuron Ltd	Proteins and extracellular vesicles

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ226750A (en)	1987-10-29	1990-09-26	Amrad Corp Ltd	Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5270191A (en)	1988-04-12	1993-12-14	Massachusetts Institute Of Technology	Method for manipulation of the cell types of eukaryotes
DE68907220T2 (de)	1988-04-12	1994-01-27	Massachusetts Inst Technology	Verfahren zur manipulation des zelltyps von eukaryonten.
US5399493A (en)	1989-06-15	1995-03-21	The Regents Of The University Of Michigan	Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
WO1991009936A1 (en)	1989-12-26	1991-07-11	Hana Biologics, Inc.	Proliferated neuron progenitor cell product and process
US5612211A (en)	1990-06-08	1997-03-18	New York University	Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5851832A (en)	1991-07-08	1998-12-22	Neurospheres, Ltd.	In vitro growth and proliferation of multipotent neural stem cells and their progeny
DE69233061T3 (de)	1991-07-08	2008-07-10	Neurospheres Holding Ltd., Calgary	Auf wachstumsfaktoren reagierende neurale vorläuferzellen, die in vitro vermehrt werden können.
EP0631618A4 (en)	1992-03-04	1995-09-27	Systemix Inc	CULTIVATION OF HEMOPOETIC STEM CELLS AND THEIR GENETOLOGICAL PRODUCTION.
US5753491A (en)	1993-04-13	1998-05-19	Us Health	Use of neuro-derived fetal cell lines for transplantation therapy
WO1994023754A1 (en)	1993-04-13	1994-10-27	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Use of neuro-derived fetal cell lines for transplantation therapy
ATE261492T1 (de)	1994-11-08	2004-03-15	Cellfactors Plc	Methode zur herstellung einer menschlichen neuralen zelllinie
AU716811B2 (en)	1994-11-14	2000-03-09	Neurospheres Holdings Ltd	Regulation of neural stem cell proliferation
US5843780A (en)	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
GB9517263D0 (en)	1995-08-23	1995-10-25	Cancer Res Campaign Tech	Expression systems
GB9518606D0 (en)	1995-09-12	1995-11-15	Inst Of Psychiatry	Neural transplantation
US5588692A (en)	1995-10-11	1996-12-31	General Motors Corporation	Push-out vehicle side door
EP0773287A1 (en) *	1995-11-07	1997-05-14	Bayer Ag	Immortalised embryonic hyppocampal cells and their use
US5770414A (en) *	1996-02-20	1998-06-23	The Regents Of The University Of California	Regulatable retrovirus system for genetic modification of cells
US7544511B2 (en) *	1996-09-25	2009-06-09	Neuralstem Biopharmaceuticals Ltd.	Stable neural stem cell line methods
EP0934403A4 (en)	1996-08-19	2001-03-14	Univ Massachusetts	ROWS OF EMBRYONIC OR STRAIN-LIKE CELLS PRODUCED BY CROSS NUCLEAR TRANSPLANTATION OF SPECIES
US20020123143A1 (en)	1997-08-22	2002-09-05	Jean Toma	Multipotent stem cells from peripheral tissues and uses thereof
US5968829A (en)	1997-09-05	1999-10-19	Cytotherapeutics, Inc.	Human CNS neural stem cells
ES2246085T3 (es)	1998-05-07	2006-02-01	University Of South Florida	Celulas de medula osea como fuente de neuronas util para reparar la medula espinal y el cerebro.
US5958767A (en)	1998-08-14	1999-09-28	The Children's Medical Center Corp.	Engraftable human neural stem cells
GB9904281D0 (en)	1999-02-24	1999-04-21	Reneuron Ltd	Transplantation
GB9907243D0 (en)	1999-03-29	1999-05-26	Reneuron Ltd	Therapy
US6399384B1 (en)	1999-09-17	2002-06-04	Reneuron Limited	Conditional immortalization of cells
US6465215B1 (en)	1999-12-14	2002-10-15	Reneuron Limited	Identification of cells for transplantation
JP2003516141A (ja) *	1999-12-07	2003-05-13	モナシュ・ユニヴァーシティ	長期細胞培養組成物とそれから誘導される遺伝的に修飾された動物
AU2001243464B2 (en)	2000-03-09	2006-04-13	Saneron Ccel Therapeutics, Inc.	Human cord blood as a source of neural tissue for repair of the brain and spinal cord
GB0005856D0 (en) *	2000-03-10	2000-05-03	Reneuron Ltd	Genetic constructs
US7250294B2 (en)	2000-05-17	2007-07-31	Geron Corporation	Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
US7049072B2 (en)	2000-06-05	2006-05-23	University Of South Florida	Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
WO2001094541A2 (en)	2000-06-05	2001-12-13	University Of South Florida	Human mesenchymal progenitor cell
WO2003029432A2 (en)	2001-10-03	2003-04-10	University Of South Florida	Human mesenchymal progenitor cell
GB0125773D0 (en)	2001-10-26	2001-12-19	Reneuron Ltd	Constructs
US20040185429A1 (en) *	2002-12-09	2004-09-23	Judith Kelleher-Andersson	Method for discovering neurogenic agents
ES2294650T3 (es) *	2004-09-30	2008-04-01	Reneuron Limited	Linea celular.

2005
- 2005-09-23 ES ES05255932T patent/ES2294650T3/es active Active
- 2005-09-23 AT AT05255932T patent/ATE373081T1/de active
- 2005-09-23 DK DK05255932T patent/DK1645626T3/da active
- 2005-09-23 DE DE602005002430T patent/DE602005002430T2/de active Active
- 2005-09-23 EP EP05255932A patent/EP1645626B1/en active Active
- 2005-09-28 JP JP2005282179A patent/JP5036156B2/ja active Active
- 2005-09-28 CA CA2521421A patent/CA2521421C/en active Active
- 2005-09-29 US US11/238,702 patent/US7416888B2/en active Active
- 2005-09-30 AU AU2005218041A patent/AU2005218041B2/en not_active Ceased
- 2005-11-21 US US11/283,621 patent/US7419827B2/en active Active
2008
- 2008-01-28 US US12/020,874 patent/US7666672B2/en active Active

Also Published As

Publication number	Publication date
AU2005218041B2 (en)	2010-09-16
US20060067918A1 (en)	2006-03-30
DE602005002430D1 (de)	2007-10-25
JP5036156B2 (ja)	2012-09-26
ES2294650T3 (es)	2008-04-01
CA2521421A1 (en)	2006-03-30
DE602005002430T2 (de)	2008-06-19
ATE373081T1 (de)	2007-09-15
JP2006122045A (ja)	2006-05-18
EP1645626B1 (en)	2007-09-12
AU2005218041A1 (en)	2006-04-13
US7666672B2 (en)	2010-02-23
CA2521421C (en)	2013-08-06
US7419827B2 (en)	2008-09-02
US20060104959A1 (en)	2006-05-18
US20080118479A1 (en)	2008-05-22
US7416888B2 (en)	2008-08-26
EP1645626A1 (en)	2006-04-12

Publication	Publication Date	Title
DK1645626T3 (da)	2008-01-21	Cellelinie
HK1173169A1 (en)	2013-05-10	Dimercaptan terminated polythioether polymers and methods for making and using the same
RS50660B (sr)	2010-06-30	Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
DK2308855T3 (da)	2013-01-28	2,4-Diaminopyrimidinderivater
MX2010002028A (es)	2010-03-15	Metodos y composiciones para modular celulas t.
EP1786831A4 (en)	2008-01-23	Alanine 2,3-aminomutases
ATE506362T1 (de)	2011-05-15	1-aza-bicycloä3.3.1ünonane
AU304926S (en)	2006-01-16	Paper trimmer
ITRM20020278A0 (it)	2002-05-17	Verricello convertibile.
ITPD20020223A1 (it)	2004-03-04	Riduttore epicloidale di tipo embricato.
ITTO20030078A1 (it)	2003-08-22	Composizioni in particolare per l'impiego con elastomeri.
ITBO20020698A1 (it)	2004-05-06	Decespugliatore di tipo perfezionato.
NL1019697A1 (nl)	2002-03-13	Stroomafnemer.
ES1051317Y (es)	2002-11-01	Mochila convertible.
Азімов et al.	2005	Êîðîòê³ â³äîìîñò³ Êîðîòê³ â³äîìîñò³ ïðî àâòîð³â ïðî àâòîð³â
ITBA20040040A1 (it)	2004-12-24	ELEFANTINO h.5,5
PL114818U1 (en)	2004-11-02	V .03
ITLC20040002A1 (it)	2004-05-06	P.p.0
TW200500081A (en)	2005-01-01	Novel rotaviruses and use thereof
ITRM20040039A1 (it)	2004-04-27	Vaccino per l'ulcera.
UY34598A (es)	2013-02-28	Antranilamidas insecticidas
HN2002000177A (es)	2002-11-02	2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso.
ITBA20040055A1 (it)	2005-03-01	Generatore n.g.2004
HUP0301680A2 (hu)	2005-03-29	Alul nyitott pontonok
ES1051120Y (es)	2002-10-16	Mecanismo modificador del efecto sonoro en sordinas.